Literature DB >> 31094304

Timing of onset and rate of decline in learning and retention in the pre-dementia phase of Alzheimer's disease.

Ellen Grober1, Yang An2, Richard B Lipton1, Claudia Kawas3, Susan M Resnick2.   

Abstract

OBJECTIVE: To examine trajectories of declines in learning and retention during the predementia phase of Alzheimer's disease (AD) using the picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT+IR).
METHOD: Learning was defined by the sum of free recall over three test trials. Retention was defined in two ways: by delayed free recall (DFR) and by savings; DFR adjusted for learning. The performances of 217 incident AD cases from the Baltimore Longitudinal Study of Aging (BLSA) were aligned based on the time that AD was first diagnosed. The predementia phase of learning and retention decline was assessed using change point models in which cognitive trajectories are described by a series of linear components with knots delineating times of accelerating decline.
RESULTS: Trajectories for both learning and DFR had two change points: the first at 6.58 (95% confidence intervals (CI): 6.56, 6.60) to 7.29 (95% CI: 6.13, 8.46) years before diagnosis followed by gradual decline over the next 4 years, and a second acceleration of decline 1.89 (0.56, 3.24) to 2.93 (95% CI: 1.56, 4.30) years before diagnosis. The change points for DFR were not significantly earlier in the predementia phase than the change points for learning. Savings had one change point, 5.3 (95% CI: 3.56, 7.04) years before diagnosis.
CONCLUSION: Both learning and DFR showed similar profiles of decline in the years prior to the clinical diagnosis of AD. When delayed recall was adjusted for initial learning, the measure was less sensitive to early disease. (JINS, 2019, 25, 699-705).

Entities:  

Keywords:  Alzheimer’s disease; free and cued selective reminding test; memory disorders; preclinical dementia; prospective studies; retention; verbal learning

Mesh:

Year:  2019        PMID: 31094304      PMCID: PMC6747692          DOI: 10.1017/S1355617719000304

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  21 in total

1.  Estimation of bivariate measurements having different change points, with application to cognitive ageing.

Authors:  C B Hall; J Ying; L Kuo; M Sliwinski; H Buschke; M Katz; R B Lipton
Journal:  Stat Med       Date:  2001-12-30       Impact factor: 2.373

Review 2.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

3.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

Authors:  K Welsh; N Butters; J Hughes; R Mohs; A Heyman
Journal:  Arch Neurol       Date:  1991-03

4.  Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.

Authors:  M Wagner; S Wolf; F M Reischies; M Daerr; S Wolfsgruber; F Jessen; J Popp; W Maier; M Hüll; L Frölich; H Hampel; R Perneczky; O Peters; H Jahn; C Luckhaus; H-J Gertz; J Schröder; J Pantel; P Lewczuk; J Kornhuber; J Wiltfang
Journal:  Neurology       Date:  2012-01-11       Impact factor: 9.910

5.  Trajectory of mild cognitive impairment onset.

Authors:  Diane B Howieson; Nichole E Carlson; M Milar Moore; Dara Wasserman; Cena D Abendroth; Jessica Payne-Murphy; Jeffrey A Kaye
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

6.  Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.

Authors:  Ellen Grober; Charles B Hall; Richard B Lipton; Alan B Zonderman; Susan M Resnick; Claudia Kawas
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

7.  Education delays accelerated decline on a memory test in persons who develop dementia.

Authors:  C B Hall; C Derby; A LeValley; M J Katz; J Verghese; R B Lipton
Journal:  Neurology       Date:  2007-10-23       Impact factor: 9.910

8.  Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample.

Authors:  Murat Bilgel; Yang An; Andrew Lang; Jerry Prince; Luigi Ferrucci; Bruno Jedynak; Susan M Resnick
Journal:  Alzheimers Dement       Date:  2014-07-14       Impact factor: 21.566

9.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

Authors:  Michael C Donohue; Reisa A Sperling; David P Salmon; Dorene M Rentz; Rema Raman; Ronald G Thomas; Michael Weiner; Paul S Aisen
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

10.  Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease.

Authors:  Yu-Ling Chang; Mark W Bondi; Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Mark W Jacobson; Anders M Dale
Journal:  Neuropsychologia       Date:  2009-12-23       Impact factor: 3.139

View more
  5 in total

1.  Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.

Authors:  Owen A Williams; Yang An; Nicole M Armstrong; Melissa Kitner-Triolo; Luigi Ferrucci; Susan M Resnick
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment.

Authors:  Ellen Grober; Cuiling Wang; Melissa Kitner-Triolo; Richard B Lipton; Claudia Kawas; Susan M Resnick
Journal:  J Int Neuropsychol Soc       Date:  2021-03-22       Impact factor: 3.114

3.  The Free and Cued Selective Reminding Test Predicts Braak Stage.

Authors:  Ellen Grober; Qi Qi; Lynn Kuo; Jason Hassenstab; Richard J Perrin; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.

Authors:  Ellen Grober; Richard B Lipton; Reisa A Sperling; Kathryn V Papp; Keith A Johnson; Dorene M Rentz; Amy E Veroff; Paul S Aisen; Ali Ezzati
Journal:  Neurology       Date:  2022-02-23       Impact factor: 9.910

5.  Memory markers in the continuum of the Alzheimer's clinical syndrome.

Authors:  Mario A Parra; Clara Calia; Vivek Pattan; Sergio Della Sala
Journal:  Alzheimers Res Ther       Date:  2022-09-30       Impact factor: 8.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.